Fecal Lactoferrin: Reliable Biomarker for Intestinal Inflammation in Pediatric IBD
Background. Optimal management of pediatric patients with inflammatory bowel disease (IBD) requires early diagnosis. Aim of the study is to compare fecal lactoferrin (FL) as biomarker of intestinal inflammation to CRP in pediatric patients with new-onset IBD. Methods. FL was measured by ELISA in sto...
Saved in:
Main Authors: | Stephan Buderus, James H. Boone, Michael J. Lentze |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2015/578527 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of Anemia in Pediatric IBD Patients and Impact on Disease Severity: Results of the Pediatric IBD-Registry CEDATA-GPGE®
by: Jan de Laffolie, et al.
Published: (2017-01-01) -
Lactoferrin Decreases the Intestinal Inflammation Triggered by a Soybean Meal-Based Diet in Zebrafish
by: Pilar E. Ulloa, et al.
Published: (2016-01-01) -
Research Progress in Lactoferrin’s Role in Alleviating Intestinal Barrier Dysfunction
by: LI Yi, REN Xinxin, WANG Qin, HE Xiaoyun
Published: (2025-01-01) -
Intestinal Immune Imbalance is an Alarm in the Development of IBD
by: Chunli Hu, et al.
Published: (2023-01-01) -
The Pediatric Patient with IBD - “Am I special?”
by: Helen Machida
Published: (1992-01-01)